⌘K

Login Start Free

Home/Filings/4/0001209191-19-038862

4//SEC Filing

WITTE OWEN N. 4

Accession 0001209191-19-038862

CIK 0001737287other

View on SEC.gov Company Profile

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 8:00 PM ET

Size

5.2 KB

Accession

0001209191-19-038862

Insider Transaction Report

Form 4

Period: 2019-06-06

Allogene Therapeutics, Inc.ALLO

Director

Transactions

Award
Stock Option (Right to Buy)
2019-06-06+26,025→ 26,025 total
Exercise: $25.95Exp: 2029-06-06→ Common Stock (26,025 underlying)

Footnotes (1)

[F1]The stock option vests in 12 equal monthly installments beginning July 6, 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1

filerCIK 0001700969

Filing Metadata

Form type: 4
Filed: Jun 23, 8:00 PM ET
Accepted: Jun 24, 8:00 PM ET
Size: 5.2 KB

View on SEC.gov